Loading...
Back
NLVX
NLV
ENLIVEX LTD
(ENLV)
2024 6-K
Follow
Summary
Share
Summary
Nasdaq Notice Received
15 May '26
Clinical Trial Approval
21 Apr '26
Token Launch Announced
8 Apr '26
New AI Initiative
26 Mar '26
Financial Results Release
25 Mar '26
Securities Agreement
24 Mar '26
FDA Approval Granted
23 Mar '26
Name Change Approved
23 Feb '26
RAIN Token Listing
10 Feb '26
Shareholder Meeting
5 Feb '26
RAIN Token Listing
26 Jan '26
Voluntary Delisting
23 Jan '26
New Token Listing
7 Jan '26
Shareholder Meeting Announc...
18 Dec '25
Virtual Fireside Chat
4 Dec '25
Private Placement Completed
26 Nov '25
Annual Meeting Update
18 Nov '25
Financial Results Report
14 Nov '25
Annual Meeting Update
10 Nov '25
Annual Meeting Scheduled
25 Sep '25
Strategic Roadmap Update
11 Sep '25
Patent Announcement
9 Sep '25
Financial Update
29 Aug '25
Investor Presentation Update
18 Aug '25
Clinical Trial Update
18 Aug '25
Webinar Announcement
14 Aug '25
Trial Completion Announcement
28 Jul '25
Financial Report
30 May '25
Presentation Announcement
23 Apr '25
Trial Enrollment Complete
21 Apr '25
Trial Announcement
3 Apr '25
Financial Statements Filed
31 Mar '25
Patent Approval News
17 Mar '25
Investor Webinar Notice
4 Mar '25
Positive Trial Results
3 Mar '25
Fraudulent News Alert
18 Feb '25
Clinical Trial Initiation
11 Dec '24
Positive Trial Results
3 Dec '24
Financial Update
29 Nov '24
Bitcoin Acquisition
20 Nov '24
Clinical Trial Update
14 Nov '24
Patient Enrollment Update
12 Nov '24
Annual Meeting Results
8 Nov '24
Annual Meeting Update
31 Oct '24
Patent Approval Update
30 Oct '24
Filing Amendment
15 Oct '24
Phase II Trial Approval
26 Sep '24
Clinical Trial Update
24 Sep '24
Annual Meeting Notice
11 Sep '24
Financial Update
30 Aug '24
Clinical Trial Approval
23 Jul '24
Trial Initiated
24 Jun '24
Investor Webinar Notice
20 Jun '24
Positive Clinical Data
17 Jun '24
Financial Report
14 Jun '24
Regulatory Approval
3 Jun '24
Securities Offering
29 May '24
Share Issuance Agreement
28 May '24
Shareholder Update
29 Apr '24
Trial Announcement
22 Apr '24
Trial Expansion Approval
16 Apr '24
Clinical Trial Results
11 Apr '24
Financial Statements Report
29 Mar '24
New Patent Granted
7 Feb '24
Share Repurchase Program
22 Jan '24
Trial Authorization
17 Jan '24
External Links:
SEC
On June 20, 2024, Enlivex Therapeutics Ltd. announced a webinar for investors scheduled on June 25, 2024, at 4:15 p.m. ET.
AI Assistant
Close
ENLIVEX LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.